Company: INMB
Filing Date: 2025-03-07
Form Type: 424B5
Source: 0001213900-25-021719
Chunk: 28

Company: Inmune Bio, Inc.
Filing Date: 2025-03-07
Form: 424B5
Chunk 28
---
us
supplement. You should carefully read both this prospectus and any prospectus supplement together with the additional information described
under “Where You Can Find More Information” before buying any securities in this offering.

The terms “INmune Bio”, the “Company,”
“we,” “our,” or “us,” in this prospectus refer to INmune Bio Inc. and its wholly-owned subsidiaries,
unless the context suggests otherwise.

<div align='center'>ii

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</div>

Some of the statements made under “Prospectus
Summary,” “Use of Proceeds,” and elsewhere in this prospectus, as well as the documents incorporated by reference herein,
including in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, constitute forward-looking statements within
the meaning of The Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology
such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,”
“believes,” “estimates,” “predicts,” “potential,” “intends,” or “continue,”
or the negative of these terms or other comparable terminology.

These forward-looking statements may include, but
are not limited to, statements related to our expected business, new product introductions, results of clinical studies, expectations
regarding regulatory clearance and the timing of FDA or non-US filings or approvals including meetings with FDA or non-U.S. regulatory
bodies, our ability to raise funds for general corporate purposes and operations, including our research activities and clinical trials,
procedures and procedure adoption, future results of operations, future financial position, our ability to generate revenues, our financing
plans and future capital requirements, anticipated costs of revenue, anticipated expenses, the effect of recent accounting pronouncements,
our anticipated cash flows, our ability to finance operations from cash flows or otherwise, and statements based on current expectations,
estimates, forecasts, and projections about the economies and markets in which we operate and intend to operate and our beliefs and assumptions
regarding these economies and markets.

Forward-looking statements are not guarantees of
future performance and are subject to risks and uncertainties. We have based these forward-looking statements on assumptions and assessments
made by our management in light of their experience and their perception of historical trends, current conditions, expected future developments,
and other factors they believe to be appropriate.

Important factors that